Catalyst Wire Dossier Catalyst Wire Dossier

ABSORB Everolimus-eluting bioresorbable vascular scaffold

everolimus-eluting bioresorbable vascular scaffold · Abbott
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABSORB Everolimus-eluting bioresorbable vascular scaffold, covering 2016-12-09 to 2016-12-09. Get the full timeline:

Most recent: Clinical Trial Update: ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

See pricing